Cortes, J E <br/><br/>
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.  [electronic resource] 

 -  The New England journal of medicine  Nov 2013 
 - 1783-96 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1306494  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Protein Kinase Inhibitors--adverse effects<br/>Pyridazines--adverse effects<br/>Thrombocytopenia--chemically induced<br/>Thrombosis--chemically induced<br/>Young Adult